| Title |
Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population
|
|---|---|
| Published in |
The Journal of Headache and Pain, December 2013
|
| DOI | 10.1186/1129-2377-14-95 |
| Pubmed ID | |
| Authors |
Delphine Magis, Simona Sava, Tullia Sasso d’Elia, Roberta Baschi, Jean Schoenen |
| Abstract |
Transcutaneous supraorbital nerve stimulation (tSNS) with the Cefaly® device was recently found superior to sham stimulation for episodic migraine prevention in a randomized trial. Its safety and efficiency in larger cohorts of headache sufferers in the general population remain to be determined.The objective of this study was to assess the satisfaction with the Cefaly® device in 2,313 headache sufferers who rented the device for a 40-day trial period via Internet. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 43% |
| Italy | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Scientists | 1 | 14% |
| Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 147 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Greece | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 143 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 19% |
| Other | 24 | 16% |
| Student > Postgraduate | 13 | 9% |
| Student > Master | 13 | 9% |
| Student > Ph. D. Student | 11 | 7% |
| Other | 28 | 19% |
| Unknown | 30 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 35% |
| Neuroscience | 20 | 14% |
| Psychology | 8 | 5% |
| Nursing and Health Professions | 7 | 5% |
| Agricultural and Biological Sciences | 5 | 3% |
| Other | 18 | 12% |
| Unknown | 38 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 143. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#286,892
of 25,380,459 outputs
Outputs from The Journal of Headache and Pain
#38
of 1,526 outputs
Outputs of similar age
#2,555
of 321,340 outputs
Outputs of similar age from The Journal of Headache and Pain
#1
of 10 outputs
Altmetric has tracked 25,380,459 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,526 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.5. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 321,340 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them